184 related articles for article (PubMed ID: 17982629)
1. Over-expression of 14-3-3sigma in budding colorectal cancer cells modulates cell migration in the presence of tenascin-C.
Ide M; Saito K; Tsutsumi S; Tsuboi K; Yamaguchi S; Asao T; Kuwano H; Nakajima T
Oncol Rep; 2007 Dec; 18(6):1451-6. PubMed ID: 17982629
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front.
Ide M; Nakajima T; Asao T; Kuwano H
Cancer Lett; 2004 Apr; 207(2):241-9. PubMed ID: 15072834
[TBL] [Abstract][Full Text] [Related]
3. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells.
Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K
Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740
[TBL] [Abstract][Full Text] [Related]
4. 14-3-3sigma is down-regulated in human prostate cancer.
Urano T; Takahashi S; Suzuki T; Fujimura T; Fujita M; Kumagai J; Horie-Inoue K; Sasano H; Kitamura T; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2004 Jul; 319(3):795-800. PubMed ID: 15184053
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of 14-3-3sigma in pancreatic cancer and its role in cell cycle regulation and apoptosis.
Guweidhi A; Kleeff J; Giese N; El Fitori J; Ketterer K; Giese T; Büchler MW; Korc M; Friess H
Carcinogenesis; 2004 Sep; 25(9):1575-85. PubMed ID: 15073049
[TBL] [Abstract][Full Text] [Related]
6. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
7. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.
Esposito I; Penzel R; Chaib-Harrireche M; Barcena U; Bergmann F; Riedl S; Kayed H; Giese N; Kleeff J; Friess H; Schirmacher P
J Pathol; 2006 Apr; 208(5):673-85. PubMed ID: 16450333
[TBL] [Abstract][Full Text] [Related]
8. The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.
Wang Z; Tropè CG; Suo Z; Trøen G; Yang G; Nesland JM; Holm R
BMC Cancer; 2008 Oct; 8():308. PubMed ID: 18950492
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3sigma expression is an independent prognostic parameter for poor survival in colorectal carcinoma patients.
Perathoner A; Pirkebner D; Brandacher G; Spizzo G; Stadlmann S; Obrist P; Margreiter R; Amberger A
Clin Cancer Res; 2005 May; 11(9):3274-9. PubMed ID: 15867223
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.
Ohno Y; Izumi M; Yoshioka K; Ohori M; Yonou H; Tachibana M
Oncol Rep; 2008 Sep; 20(3):511-6. PubMed ID: 18695899
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic silencing of 14-3-3sigma in cancer.
Lodygin D; Hermeking H
Semin Cancer Biol; 2006 Jun; 16(3):214-24. PubMed ID: 16698281
[TBL] [Abstract][Full Text] [Related]
12. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
13. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of BMP7 in human colorectal cancer.
Motoyama K; Tanaka F; Kosaka Y; Mimori K; Uetake H; Inoue H; Sugihara K; Mori M
Ann Surg Oncol; 2008 May; 15(5):1530-7. PubMed ID: 18259822
[TBL] [Abstract][Full Text] [Related]
15. Targeted proteomic analysis of 14-3-3sigma in nasopharyngeal carcinoma.
Huang WG; Cheng AL; Chen ZC; Peng F; Zhang PF; Li MY; Li F; Li JL; Li C; Yi H; Li XH; Yi B; Xiao ZQ
Int J Biochem Cell Biol; 2010 Jan; 42(1):137-47. PubMed ID: 19828132
[TBL] [Abstract][Full Text] [Related]
16. Tumor budding is predictive of lymphatic involvement and lymph node metastases in submucosal invasive colorectal adenocarcinomas and in non-polypoid compared with polypoid growths.
Ogawa T; Yoshida T; Tsuruta T; Tokuyama W; Adachi S; Kikuchi M; Mikami T; Saigenji K; Okayasu I
Scand J Gastroenterol; 2009; 44(5):605-14. PubMed ID: 19221929
[TBL] [Abstract][Full Text] [Related]
17. Laminin 5 beta3 and gamma2 chains are frequently coexpressed in cancer cells.
Akimoto S; Nakanishi Y; Sakamoto M; Kanai Y; Hirohashi S
Pathol Int; 2004 Sep; 54(9):688-92. PubMed ID: 15363037
[TBL] [Abstract][Full Text] [Related]
18. A novel in vitro model of lymphatic metastasis from colorectal cancer.
Yoo PS; Mulkeen AL; Dardik A; Cha CH
J Surg Res; 2007 Nov; 143(1):94-8. PubMed ID: 17640671
[TBL] [Abstract][Full Text] [Related]
19. Role of fibrillar Tenascin-C in metastatic pancreatic cancer.
Chen J; Chen Z; Chen M; Li D; Li Z; Xiong Y; Dong J; Li X
Int J Oncol; 2009 Apr; 34(4):1029-36. PubMed ID: 19287959
[TBL] [Abstract][Full Text] [Related]
20. Tumor cell-microenvironment interaction models coupled with clinical validation reveal CCL2 and SNCG as two predictors of colorectal cancer hepatic metastasis.
Hu H; Sun L; Guo C; Liu Q; Zhou Z; Peng L; Pan J; Yu L; Lou J; Yang Z; Zhao P; Ran Y
Clin Cancer Res; 2009 Sep; 15(17):5485-93. PubMed ID: 19706805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
